Executive Management Team members

The Executive Management Team of the Francis Crick Institute manages its day-to-day activities. Click on the name of the Executive Team member to find out more.

  1. Sir Paul Nurse, Director and Chief Executive

    Sir Paul Nurse was appointed in January 2011 following seven years as President of Rockefeller University in New York. He is also President of the Royal Society.

    Before moving to the US, Paul spent more than three decades as a research scientist in the UK. His senior positions included Chair of Microbiology at the University of Oxford and Director General of the Imperial Cancer Research Fund (ICRF). He played a major role in ICRF’s merger with the Cancer Research Campaign in 2002 to form Cancer Research UK — which he led as Chief Executive.

    Paul, along with Tim Hunt and Lee Hartwell, was awarded the Nobel Prize in Physiology or Medicine in 2001. He also won the US Albert Lasker Award and numerous other awards and medals. His current research at Cancer Research UK’s London Research Institute focuses on the molecular machinery that drives cell division and controls cell shape.

  2. Professor David Roblin, Chief Operating Officer (COO) and Director of Scientific Translation

    David Roblin joined the Crick in September 2014. As well as taking on the role of COO, David also leads translational activities for the Crick as it accelerates its science for health and wealth benefits.  

    David practiced medicine for five years before entering the pharmaceutical industry. He has held significant leadership roles in his pharmaceutical career, with general management, research, development and commercial responsibilities. He was formerly Senior Vice President, Head of Research, for Pfizer's European research and development. Since he left Pfizer in early 2011, David has been Chief Medical Officer and a Non-Executive Director to a number of biotech companies. He also serves on the Major Awards Committee of the UK's Biomedical Catalyst Fund. 

    David has a degree in biochemistry from University College London and later qualified in medicine from St George's Hospital. He is a Fellow of the Royal College of Physicians, a member of the Faculty of Pharmaceutical Medicine and an honorary Professor at Swansea University.



  3. John Cooper, Projects Director

    John Cooper joined the Francis Crick Institute in 2009 and was COO and Deputy CEO until September 2014 when he handed over to David Roblin, the institute's long-term COO. John now chairs the Construction Project Board and the Transition Delivery Steering Group, and will lead on various other projects up until the opening of the Crick in late 2015, following which he plans to retire.

    Prior to the Crick John was Director of Resources at the Wellcome Trust, responsible for a wide range of business services, various construction and other large projects, and for the Welllcome Trust Genome Campus.

    John is a Director of Stevenage Bioscience Catalyst, a joint venture between the Wellcome Trust and GlaxoSmithKline.

    Before joining the Wellcome Trust in 1999, John spent 30 years in the commercial electronics industry.

  4. Dr Richard Treisman, Director, LRI

    Richard Treisman is Director of the Cancer Research UK London Research Institute, appointed in 2002 after three years as Director of Laboratory Research at the Imperial Cancer Research Fund (ICRF). He joined ICRF in 1988 from the MRC Laboratory of Molecular Biology in Cambridge.

    Richard was elected a Fellow of the Royal Society in 1994 and a Fellow of the Academy of Medical Sciences in 2000. He received the EMBO Medal in 1995 and the Louis Jeantet prize in 2002.

    His current research interest is the interaction between cytoskeletal dynamics and transcriptional regulation.

  5. Steve Gamblin, Director of Science Operations

    Dr Steve Gamblin is Director of Science Operations at the Crick and Director of Research at the MRC's National Institute for Medical Research.

    Steve's research has provided critical insights into the fundamental mechanisms underlying cellular signalling and disease processes. Steve is a Fellow of the Academy of Medical Sciences, a member of EMBO, and was elected as a Fellow of the Royal Society in 2011. 

  6. Melanie Chatfield, General Counsel

    Melanie Chatfield trained and qualified as a solicitor with the City law firm Rowe & Maw, specialising in mergers and acquisitions. Since 1993 she has pursued a career as an in-house legal adviser.

    Prior to joining the Francis Crick Institute in 2009, Melanie worked on a number of major development projects in the UK and overseas. Her experience in this field includes seven years with an international port developer and operator which is part of the Hong Kong based conglomerate Hutchison Whampoa Limited.

  7. John Macey, HR Director

    John has over 18 years experience in HR. He began his career in fast-paced acute healthcare organisations, mainly within the NHS and held roles at all levels, including executive board. Most recently John was an HR Director with Cancer Research UK working alongside Scientific and Fundraising colleagues and has also held Non Executive Director roles with smaller charities.  

    John is a member of the Chartered Institute of Personnel and Development and throughout his career he has led numerous change initiatives, large and small, in merger, financially constrained and growth environments. He has been aligned to the Crick project for several years and joined the team full time in September 2013. 

  8. Jo Woods, Chief Financial Officer

    Jo is a finance professional whose career spans both consulting and in-house roles. Prior to joining the Crick , Jo was the Head of Finance and Operations  for the Boston Consulting Group UK LLP. Until 2011,Jo was the Finance Director for Audio & Music within the BBC, where she developed and implemented significant savings programmes whilst safeguarding programme quality. Prior to her BBC career, she was a management consultant with Coopers & Lybrand specialising in project management and finance efficiency programmes.

    Jo is a graduate of Merton College Oxford and a fellow of the Chartered Institute of Management Accountants.

  9. Andy Smith, Construction Director

    Andy Smith qualified as a Chartered Surveyor and has more than 25 years' experience in the construction industry. He came to the Francis Crick Institute in 2009 having held senior positions on several major developments including the Heron Plaza projects, The Millennium Dome and the main Terminal 5 building.

    Andy has significant large-scale laboratory experience gained through a six-year secondment to the SmithKline Beecham project team responsible for the New Frontiers Science Park.

  10. Alison Davis, ICT Director

    Alison has been working in IT, mainly in the pharmaceutical industry, for 28 years.  For 15 of those years, she has worked in IT Director roles, delivering IT solutions, IT-enabled change and organisational development of IT.  

    Immediately before joining the Francis Crick Institute, Alison held the role of Director of Information Management for the Medicines & Healthcare Products Regulatory Agency.  During her time in this role, she also led the Vision project component of the Agency's accommodation programme to relocate approximately 1000 staff to new premises, which included a move to open plan working and significant associated organisational change.  

    Alison graduated with a degree in Chemistry in 1984 and worked as a research Chemist with Glaxo before moving into their IT department.

  11. Nick Carter, Director of Building Services

    Nick joined the Francis Crick Institute as Director of Building Services in September 2013. He is a Chartered Engineer and a Member of the Institution of Mechanical Engineers with over 25 years experience leading Engineering and Operations teams in areas such as Site Utilities, Health and Safety, Maintenance, Energy, and Environmental Services. 

    Nick's experience spans a number of industrial sectors including chemicals, pulp and paper, renewable energy, and pharmaceuticals. This has also included several years with Pfizer at Sandwich where he was Director of Engineering, Maintenance and Utilities, with responsibility for the engineering and facilities maintenance of all pharmaceutical research and manufacturing operations at the 400-acre site.

  12. Michael Schuitevoerder, Transition Programme Director

    Michael has a career background in medical research and healthcare. He has twenty years of experience in research and development with medium and large pharmaceutical companies, and twelve years experience as an independent consultant. His focus has been on supporting healthcare organisations, the NHS, universities, and the pharmaceutical industry to deliver effective transformation and integration between medical research and treatment. 

    Michael's domain specialisation is the exploitation of information and medical technologies to transform organisations. He is a Chartered IT Professional.

  13. Professor Malcolm Irving, King's College London

    Malcolm Irving is Professor of Biophysics and Director of the Randall Division of Cell and Molecular Biophysics at King’s College London. He also chairs the Research Committee of the School of Biomedical Sciences at King’s. His main research interest is in molecular mechanisms in contraction and regulation of skeletal and cardiac muscle.

    Malcolm was elected a Fellow of the Royal Society in 2003 and a Fellow of the Academy of Medical Sciences in 2006.

  14. Professor Geraint Rees, UCL

    Geraint Rees is Deputy Head of Faculty of the UCL Faculty of Brain Sciences and Director of the UCL Institute of Cognitive Neuroscience. His work seeks to explore, characterise and ultimately modify human consciousness in both health and disease. He is passionately commited to training the next generation of scientists and clinician scientists and has a strategic leadership role coordinating UCL's MRC and NIHR training portfolio. 

    Geraint was elected a Fellow of the Academy of Medical Sciences in 2010 and is a Fellow of the Royal College of Physicians.

  15. Professor Jonathan Weber, Imperial College London

    Jonathan Weber is Deputy Principal (Research) and Clinical Professor, Department of Medicine, Imperial College London. He was appointed in 1990 to establish a department studying HIV and other sexually transmitted infections.

    A clinician by training, his work includes fundamental research on humoral immunity in HIV infection and early phase clinical investigation of emerging antiretroviral drugs and potential HIV vaccines.

    Jonathan is a Fellow of the Academy of Medical Sciences, a Fellow of the Royal College of Physicians, and a Fellow of the Royal College of Pathologists. He advises WHO, UNAIDS, DfID and EU on aspects of HIV infection.

  16. Sir Keith Peters, Consultant, advising on the Crick’s clinical, translational and innovation strategy

    Keith Peters, who played an important part in developing the original idea for the Crick when he was interim director at the National Institute for Medical Research advises the project on clinical and translational work and innovation in the run up to the opening of the Institute.

    Keith is currently a senior consultant in research and development for GSK and is a former Regius professor of medicine at Cambridge University. His expertise and experience will be a real asset to the project.